SLU peptide stacks on TikTok: what the science actually says

What did @mitrifit actually say?

The creator recommended five non-injectable compounds for fat loss aimed at people who avoid needles: SLU-PP-332, GC-1, GW501516 (cardarine), tessofensine, and 5-amino-1MQ. He suggested starting SLU-PP-332 at "500 micrograms a day" split around training and fasting windows, and added that cardarine "will help with endurance throughout cardio and just overall fat loss benefits." He also dismissed ostarine as "a storm" while recommending these alternatives as cleaner options.

To be clear: this is a TikTok creator giving unsolicited dosing guidance on research chemicals, most of which have never completed human clinical trials. That context matters before you consider a single word of it.

Does the science back this up?

Partially, and unevenly. Some of these compounds have real mechanistic data behind them. Others have serious safety red flags that the creator glossed over entirely.

SLU-PP-332 is a synthetic ERR (estrogen-related receptor) agonist that activates genes associated with endurance and fatty acid oxidation. Animal data from Anand et al. (2023, Journal of Medicinal Chemistry) showed improved exercise capacity and fat metabolism in mice. There are zero published human trials. GW501516 (cardarine) has legitimate PPAR-delta agonist activity, but GlaxoSmithKline abandoned it in 2007 after it caused rapid, dose-dependent cancer development across multiple organ systems in animal studies. That is not a minor footnote. Tessofensine has actual Phase II human trial data for obesity (Astrup et al., 2008, The Lancet), showing meaningful weight loss, but it works as a triple monoamine reuptake inhibitor, meaning it raises blood pressure and heart rate in a meaningful percentage of users. 5-amino-1MQ blocks NNMT (nicotinamide N-methyltransferase) and has interesting metabolic data in rodents (Neelakantan et al., 2019, Nature Communications), but again, no human trials exist.

What did they get right and what did they miss?

Credit where it is due: steering needle-averse people away from injectables is a reasonable framing, and flagging ostarine as having suppressive risk shows some awareness. Calling it "a storm" is actually fair shorthand for SARM-induced hormonal suppression.

But here is where the video falls apart. GW501516 is not a minor omission. The creator mentioned it casually as a cardio and fat loss aid without a single word about the carcinogenicity data. WADA has banned it not just for performance enhancement but specifically because of those cancer findings. Recommending it to 179,000 viewers as a straightforward fat loss tool is genuinely irresponsible. Similarly, tessofensine's cardiovascular effects were the primary reason it stalled in drug development. Recommending it to a general audience without flagging hypertension risk is incomplete at best. GC-1, a thyroid receptor beta agonist, also carries cardiovascular and bone density concerns in the literature that were not mentioned.

What should you actually know?

None of these five compounds are FDA-approved for fat loss. Most are research chemicals that exist in a legal gray zone, sold as "not for human consumption" by peptide vendors. That is not a technicality. It means no standardized dosing, no manufacturing oversight, and no long-term human safety data for most of them.

Tessofensine is the one compound here with the most credible human evidence, but it is not approved in the US and is being studied under controlled clinical conditions. The gap between "works in a Phase II trial with medical supervision" and "buy it from a peptide vendor and stack it with four other research chemicals" is enormous.

If fat loss is the goal, the compounds with the strongest human evidence remain GLP-1 receptor agonists, prescribed through legitimate telehealth channels with proper screening and monitoring. Research chemicals are not a workaround. They are a different category of risk entirely.